<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1765275" created="09/01/2007" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>1765275</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="transcription_factor_requirement" sem="Other"><term id="T2" lex="transcription_factor" sem="Protein_family_or_group">Transcription factor</term> requirements</term> for <term id="T3" lex="U2_snRNA-encoding_gene_activation" sem="Other"><term id="A1" sem="DNA_domain_or_region"><term id="T4" lex="U2_snRNA" sem="RNA_family_or_group">U2 snRNA</term>-encoding gene</term> activation</term> in <term id="T5" lex="B_lymphoid_cell" sem="Cell_natural">B lymphoid cells</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Positive_regulation"/>
<theme idref="E2"/>
<cause idref="T2"/>
<clue>Transcription factor <clueType>requirements</clueType> <linkTheme>for</linkTheme> U2 snRNA-encoding gene activation in B lymphoid cells.</clue>
</event>
<event KT="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="A1"/>
<clue>Transcription factor requirements for U2 snRNA-encoding gene <clueType>activation</clueType> <clueLoc>in B lymphoid cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Transcription of a human <term id="T6" lex="U2_small_nuclear_RNA(snRNA)-encoding_gene" sem="DNA_domain_or_region"><term id="A20" sem="DNA_domain_or_region">U2</term> small nuclear RNA(<term id="A2" sem="DNA_domain_or_region">snRNA)-encoding gene</term></term> in <term id="T7" lex="HeLa_cell" sem="Cell_cultured">HeLa cells</term> requires a <term id="A21" sem="DNA_domain_or_region"><term id="T8" lex="distal_enhancer_element" sem="DNA_domain_or_region">distal enhancer element</term>, which is composed of one <term id="T9" lex="octamer_motif" sem="DNA_domain_or_region">octamer motif</term> (<term id="T10" lex="Oct" sem="DNA_domain_or_region">Oct</term>) and three <term id="T11" lex="Sp_1-binding_site" sem="DNA_domain_or_region">Sp 1-binding sites</term></term>.</sentence>
<event KT="Other" id="E3">
<type class="Transcription"/>
<theme idref="A20" idref1="A2"/>
<clue><clueType>Transcription</clueType> <linkTheme>of</linkTheme> a human U2 small nuclear RNA(snRNA)-encoding gene <clueLoc>in HeLa cells</clueLoc> requires a distal enhancer element, which is composed of one octamer motif (Oct) and three Sp 1-binding sites.</clue>
</event>
<event KT="Fact" id="E4">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="A21"/>
<clue>Transcription of a human U2 small nuclear RNA(snRNA)-encoding gene in HeLa cells <clueType>requires</clueType> a distal enhancer element, which is composed of one octamer motif (Oct) and three Sp 1-binding sites.</clue>
<comment>TPS: A21</comment></event>
<sentence id="S3">To study the <term id="T12" lex="transcription_factor_requirement" sem="Other"><term id="T13" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term> requirement</term> in <term id="T14" lex="B-cell" sem="Cell_natural">B-cells</term>, different <term id="T15" lex="U2_enhancer_construction" sem="DNA_molecule">U2 enhancer constructions</term> were transfected into the <term id="T16" lex="lymphoid_cell_line" sem="Cell_cultured">lymphoid cell line</term>, <term id="T17" lex="BJA-B" sem="Cell_cultured">BJA-B</term>.</sentence>
<event KT="Investigation" id="E5" uncertainty="doubtful">
<type class="Positive_regulation"/>
<cause idref="T13"/>
<clue>To <clueKT>study</clueKT> the transcription factor <clueType>requirement</clueType> <clueLoc>in B-cells</clueLoc>, different U2 enhancer constructions were transfected into the lymphoid cell line, BJA-B.</clue>
<comment>NO THEME</comment></event>
<event KT="Method" id="E6">
<type class="Artificial_process"/>
<theme idref="T15"/>
<theme idref="T17"/>
<clue>To study the transcription factor requirement in B-cells, different U2 enhancer constructions were <clueType>transfected</clueType> <linkTheme>into</linkTheme> the lymphoid cell line, BJA-B.</clue>
</event>
<sentence id="S4">The results showed that the activation of <term id="A4" sem="RNA_family_or_group">U2 snRNA</term> transcription in <term id="T18" lex="B-cell" sem="Cell_natural">B-cells</term> also requires an <term id="A3" sem="DNA_domain_or_region">enhancer comprising both the <term id="T19" lex="Oct" sem="DNA_domain_or_region">Oct</term> and at least one <term id="T20" lex="Sp_1-binding_site" sem="DNA_domain_or_region">Sp 1-binding site</term></term>.</sentence>
<event id="E7">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<clue>The results showed that the <clueType>activation</clueType> <linkTheme>of</linkTheme> U2 snRNA transcription in B-cells also requires an enhancer comprising both the Oct and at least one Sp 1-binding site.</clue>
</event>
<event id="E8">
<type class="Transcription"/>
<theme idref="A4"/>
<clue>The results showed that the activation of U2 snRNA <clueType>transcription</clueType> <clueLoc>in B-cells</clueLoc> also requires an enhancer comprising both the Oct and at least one Sp 1-binding site.</clue>
</event>
<event KT="Analysis" id="E9">
<type class="Positive_regulation"/>
<theme idref="E7"/>
<cause idref="A3"/>
<clue>The results <clueKT>showed</clueKT> that the activation of U2 snRNA transcription in B-cells also <clueType>requires</clueType> an enhancer comprising both the Oct and at least one Sp 1-binding site.</clue>
<comment>TPS: A3</comment></event>
<sentence id="S5">Deletion of all the <term id="T21" lex="Sp_1-binding_site" sem="DNA_domain_or_region">Sp 1-binding sites</term> from the <term id="T22" lex="enhancer" sem="DNA_domain_or_region">enhancer</term> reduces transcription by 80-90% in HeLa, as well as in <term id="T23" lex="BJA-B_cell" sem="Cell_cultured">BJA-B cells</term>, whereas the removal of the <term id="T24" lex="octamer-binding_site" sem="DNA_domain_or_region">octamer-binding site</term> reduces transcription to levels below detection in both cell types.</sentence>
<event id="E10">
<type class="Mutagenesis"/>
<theme idref="T21"/>
<theme idref="A3"/>
<clue><clueType>Deletion</clueType> <linkTheme>of</linkTheme> all the Sp 1-binding sites <linkTheme>from</linkTheme> <corefTheme>the enhancer</corefTheme> reduces transcription by 80-90% in HeLa, as well as in BJA-B cells, whereas the removal of the octamer-binding site reduces transcription to levels below detection in both cell types.</clue>
<comment>ARTIFICIAL</comment></event>
<event Manner="High" id="E11">
<type class="Negative_regulation"/>
<theme idref="E3"/>
<theme idref="E3"/>
<cause idref="E10"/>
<clue>Deletion of all the Sp 1-binding sites from the enhancer <clueType>reduces</clueType> <corefTheme>transcription</corefTheme> <clueManner>by 80-90%</clueManner> <clueLoc>in HeLa</clueLoc>, as well as in BJA-B cells, whereas the removal of the octamer-binding site reduces transcription to levels below detection in both cell types.</clue>
</event>
<event Manner="High" id="E12">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="E10"/>
<clue>Deletion of all the Sp 1-binding sites from the enhancer <clueType>reduces</clueType> <corefTheme>transcription</corefTheme> <clueManner>by 80-90%</clueManner> in HeLa, as well as <clueLoc>in BJA-B cells</clueLoc>, whereas the removal of the octamer-binding site reduces transcription to levels below detection in both cell types.</clue>
</event>
<event id="E13">
<type class="Mutagenesis"/>
<theme idref="T24"/>
<theme idref="A3"/>
<clue>Deletion of all the Sp 1-binding sites from the enhancer reduces transcription by 80-90% in HeLa, as well as in BJA-B cells, whereas the <clueType>removal</clueType> <linkTheme>of</linkTheme> the octamer-binding site reduces transcription to levels below detection in both cell types.</clue>
<comment>TPS: A3; ARTIFICIAL</comment></event>
<event Manner="Low" id="E14">
<type class="Negative_regulation"/>
<theme idref="E3"/>
<cause idref="E13"/>
<clue>Deletion of all the Sp 1-binding sites from the enhancer reduces transcription by 80-90% in HeLa, as well as in BJA-B cells, whereas the removal of the octamer-binding site <clueType>reduces</clueType> <corefTheme>transcription</corefTheme> to levels <clueManner>below detection</clueManner> <clueLoc>in both cell types</clueLoc>.</clue>
</event>
<sentence id="S6"><term id="A5" sem="DNA_domain_or_region">Enhancers containing a single <term id="T25" lex="Oct" sem="DNA_domain_or_region">Oct</term></term> have, nevertheless, the capacity to partially activate <term id="T26" lex="U2_snRNA_transcription" sem="Other"><term id="T27" lex="U2_snRNA" sem="RNA_family_or_group">U2 snRNA</term> transcription</term> in both <term id="T28" lex="HeLa_cell" sem="Cell_cultured">HeLa cells</term>, in which only <term id="A6" sem="Protein_molecule">OTF-1</term> is expressed, and in <term id="T29" lex="BJA-B_cell" sem="Cell_cultured">BJA-B cells</term> in which <term id="T30" lex="OTF-2" sem="Protein_molecule">OTF-2</term> is the predominantly expressed <term id="T31" lex="octamer-binding_factor" sem="Protein_family_or_group">octamer-binding factor</term>.</sentence>
<event CL="L2" KT="Analysis" id="E16">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="A5"/>
<clue>Enhancers containing a single Oct have, nevertheless, the <clueKT><clueCL>capacity to</clueCL></clueKT> partially <clueType>activate</clueType> U2 snRNA transcription in both HeLa cells, in which only OTF-1 is expressed, and in BJA-B cells in which OTF-2 is the predominantly expressed octamer-binding factor.</clue>
<comment>TPS: A5</comment></event>
<event CL="L2" KT="Analysis" id="E21">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="A5"/>
<clue>Enhancers containing a single Oct have, nevertheless, the <clueKT><clueCL>capacity to</clueCL></clueKT> partially <clueType>activate</clueType> U2 snRNA transcription in both HeLa cells, in which only OTF-1 is expressed, and in BJA-B cells in which OTF-2 is the predominantly expressed octamer-binding factor.</clue>
<comment>TPS: A5</comment></event>
<event KT="Other" id="E17">
<type class="Transcription"/>
<theme idref="T27"/>
<clue>Enhancers containing a single Oct have, nevertheless, the capacity to partially activate U2 snRNA <clueType>transcription</clueType> <clueLoc>in</clueLoc> both <clueLoc>HeLa cells, in which only OTF-1 is expressed</clueLoc>, and in BJA-B cells in which OTF-2 is the predominantly expressed octamer-binding factor.</clue>
</event>
<event KT="Other" id="E18">
<type class="Transcription"/>
<theme idref="T27"/>
<clue>Enhancers containing a single Oct have, nevertheless, the capacity to partially activate U2 snRNA <clueType>transcription</clueType> in both HeLa cells, in which only OTF-1 is expressed, and <clueLoc>in BJA-B cells in which OTF-2 is the predominantly expressed octamer-binding factor</clueLoc>.</clue>
</event>
<event id="E19">
<type class="Gene_expression"/>
<theme idref="A6"/>
<clue>Enhancers containing a single Oct have, nevertheless, the capacity to partially activate U2 snRNA transcription in both <clueLoc>HeLa cells</clueLoc>, in which only OTF-1 is <clueType>expressed</clueType>, and in BJA-B cells in which OTF-2 is the predominantly expressed octamer-binding factor.</clue>
</event>
<event id="E20">
<type class="Gene_expression"/>
<theme idref="T30"/>
<clue>Enhancers containing a single Oct have, nevertheless, the capacity to partially activate U2 snRNA transcription in both HeLa cells, in which only OTF-1 is expressed, and <clueLoc>in BJA-B cells</clueLoc> in which OTF-2 is the predominantly <clueType>expressed</clueType> octamer-binding factor.</clue>
</event>
<sentence id="S7">The most likely interpretation of our results is that both the ubiquitous <term id="T32" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term>, <term id="T33" lex="OTF-1" sem="Protein_molecule">OTF-1</term>, and the <term id="T34" lex="B-cell-specific_transcription_factor" sem="Protein_family_or_group">B-cell-specific <term id="T35" lex="transcription_factor" sem="Protein_family_or_group">transcription factor</term></term>, <term id="T36" lex="OTF-2" sem="Protein_molecule">OTF-2</term>, can activate <term id="T37" lex="U2_snRNA_transcription" sem="Other"><term id="T38" lex="U2_snRNA" sem="RNA_family_or_group">U2 snRNA</term> transcription</term>.</sentence>
<event CL="L2" KT="Analysis" id="E22">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="T33"/>
<clue>The most likely <clueKT>interpretation</clueKT> of our results is that both the ubiquitous transcription factor, OTF-1, and the B-cell-specific transcription factor, OTF-2, <clueCL>can</clueCL> <clueType>activate</clueType> U2 snRNA transcription.</clue>
</event>
<event CL="L2" KT="Analysis" id="E23">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="T36"/>
<clue>The most likely <clueKT>interpretation</clueKT> of our results is that both the ubiquitous transcription factor, OTF-1, and the <clueLoc>B-cell</clueLoc>-specific transcription factor, OTF-2, <clueCL>can</clueCL> <clueType>activate</clueType> U2 snRNA transcription.</clue>
</event>
<event KT="Other" id="E24">
<type class="Transcription"/>
<theme idref="T38"/>
<clue>The most likely interpretation of our results is that both the ubiquitous transcription factor, OTF-1, and the B-cell-specific transcription factor, OTF-2, can activate U2 snRNA <clueType>transcription</clueType>.</clue>
</event>
<sentence id="S8">The results also revealed a similar functional cooperation between the <term id="A7" sem="Protein_family_or_group">transcription factors</term> which bind to the <term id="T39" lex="Oct" sem="DNA_domain_or_region">Oct</term> and the adjacent <term id="T40" lex="Sp_1-binding_site" sem="DNA_domain_or_region">Sp 1<term id="A10" sem="DNA_domain_or_region">-binding site</term></term> in <term id="T41" lex="BJA-B_cell" sem="Cell_cultured">BJA-B cells</term>, as has been observed in <term id="T42" lex="HeLa_cell" sem="Cell_cultured">HeLa cells</term>, since a template which contains a weak binding site for <term id="T43" lex="OTF" sem="DNA_domain_or_region">OTFs</term> expresses <term id="T44" lex="wild-type_level" sem="Other">wild-type levels</term> of <term id="T45" lex="U2_snRNA" sem="RNA_family_or_group">U2 snRNA</term> in both cell types when the weak <term id="T46" lex="octamer-binding_site" sem="DNA_domain_or_region">octamer-binding site</term> is combined with a <term id="T47" lex="Sp_1-binding_site" sem="DNA_domain_or_region">Sp 1-binding site</term>.</sentence>
<event KT="Analysis" id="E25">
<type class="Correlation"/>
<theme idref="A7"/>
<clue>The results also <clueKT>revealed</clueKT> a similar <clueType>functional cooperation</clueType> <linkTheme>between</linkTheme> <corefTheme>the transcription factors</corefTheme> which bind to the Oct and the adjacent Sp 1-binding site in BJA-B cells, as has been observed in HeLa cells, since a template which contains a weak binding site for OTFs expresses wild-type levels of U2 snRNA in both cell types when the weak octamer-binding site is combined with a Sp 1-binding site.</clue>
</event>
<event KT="Other" id="E26">
<type class="Binding"/>
<theme idref="A7"/>
<theme idref="T39" idref1="A10"/>
<clue>The results also revealed a similar functional cooperation between the transcription factors which <clueType>bind</clueType> <linkTheme>to</linkTheme> the Oct and the adjacent Sp 1-binding site <clueLoc>in BJA-B cells</clueLoc>, as has been observed in HeLa cells, since a template which contains a weak binding site for OTFs expresses wild-type levels of U2 snRNA in both cell types when the weak octamer-binding site is combined with a Sp 1-binding site.</clue>
</event>
<event KT="Other" id="E30">
<type class="Binding"/>
<theme idref="A7"/>
<theme idref="T39" idref1="A10"/>
<clue>The results also revealed a similar functional cooperation between the transcription factors which <clueType>bind</clueType> <linkTheme>to</linkTheme> the Oct and the adjacent Sp 1-binding site in BJA-B cells, as has been observed <clueLoc>in HeLa cells</clueLoc>, since a template which contains a weak binding site for OTFs expresses wild-type levels of U2 snRNA in both cell types when the weak octamer-binding site is combined with a Sp 1-binding site.</clue>
</event>
<event KT="Other" id="E27">
<type class="Binding"/>
<theme idref="A7"/>
<theme idref="T40"/>
<clue>The results also revealed a similar functional cooperation between the transcription factors which <clueType>bind</clueType> <linkTheme>to</linkTheme> the Oct and the adjacent Sp 1-binding site <clueLoc>in BJA-B cells</clueLoc>, as has been observed in HeLa cells, since a template which contains a weak binding site for OTFs expresses wild-type levels of U2 snRNA in both cell types when the weak octamer-binding site is combined with a Sp 1-binding site.</clue>
</event>
<event KT="Other" id="E15">
<type class="Binding"/>
<theme idref="A7"/>
<theme idref="T40"/>
<clue>The results also revealed a similar functional cooperation between the transcription factors which <clueType>bind</clueType> <linkTheme>to</linkTheme> the Oct and the adjacent Sp 1-binding site in BJA-B cells, as has been observed <clueLoc>in HeLa cells</clueLoc>, since a template which contains a weak binding site for OTFs expresses wild-type levels of U2 snRNA in both cell types when the weak octamer-binding site is combined with a Sp 1-binding site.</clue>
</event>
<event id="E28">
<type class="Transcription"/>
<theme idref="T45"/>
<clue>The results also revealed a similar functional cooperation between the transcription factors which bind to the Oct and the adjacent Sp 1-binding site in BJA-B cells, as has been observed in HeLa cells, since a template which contains a weak binding site for OTFs <clueType>expresses</clueType> wild-type levels <linkTheme>of</linkTheme> U2 snRNA <clueLoc>in both cell types</clueLoc> when the weak octamer-binding site is combined with a Sp 1-binding site.</clue>
</event>
<event id="E29">
<type class="Positive_regulation"/>
<theme idref="E28"/>
<cause idref="T46"/>
<cause idref="T47"/>
<clue>The results also revealed a similar functional cooperation between the transcription factors which bind to the Oct and the adjacent Sp 1-binding site in BJA-B cells, as has been observed in HeLa cells, since a template which contains a weak binding site for OTFs expresses wild-type levels of U2 snRNA in both cell types <linkCause>when</linkCause> the weak octamer-binding site is <linkCause>combined with</linkCause> a Sp 1-binding site.</clue>
<comment>NO CLUETYPE</comment></event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
